NCT00246324 - Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta 1a, oral doxycycline

Patients took intramuscular interferon beta 1a, 30 micrograms, for 3 months then added oral doxycycline, 100 daily with the interferon for 4 months.

Trial Locations (1)

LSU Health Sciences Center Shreveport, Shreveport